| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/2009 | WO2008110585A3 Compositions and methods for preventing and treating mucositis and weight loss |
| 03/05/2009 | WO2008109531A4 Nucleic acid compounds for inhibiting hsd11b1 expression and uses thereof |
| 03/05/2009 | WO2008109520A3 Nucleic acid compounds for inhibiting cxc gene expression and uses thereof |
| 03/05/2009 | WO2008109375A3 Nucleic acid compounds for inhibiting pik3c gene expression and uses thereof |
| 03/05/2009 | WO2008108322A3 Composition and method for protecting mitochondria |
| 03/05/2009 | WO2008088935A3 Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives |
| 03/05/2009 | WO2008086483A3 Modulation of neurogenesis with use of modafinil |
| 03/05/2009 | WO2008080092A8 Compositions comprising bile acid sequestrants for treating esophageal disorders |
| 03/05/2009 | WO2008070447A3 Anti-viral compounds |
| 03/05/2009 | WO2008062276A3 Acetylene derivatives as stearoyl coa desaturase inhibitors |
| 03/05/2009 | WO2008061902A3 Targeting of l-3-hydroxyacyl-coenzyme a dehydrogenase, short chain (hadhsc) in disorders of glucose homeostasis |
| 03/05/2009 | WO2008055068A3 Inhibitors of histone deacetylase |
| 03/05/2009 | WO2008035371A4 Dietary anti-bacterial compositions |
| 03/05/2009 | WO2008024893A3 Derivatives of uric and thiouric acid for oxidative stress-related diseases |
| 03/05/2009 | WO2008024485A3 Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent |
| 03/05/2009 | WO2008024374A3 Inhibitors of pancreatic phospholipase a2 for altering cholesterol and fat uptake |
| 03/05/2009 | WO2008023258A8 Piperidine derivatives |
| 03/05/2009 | WO2008012441A3 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 03/05/2009 | WO2008010073A8 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine |
| 03/05/2009 | WO2008001391A3 Site-specific inhibitors of histone methyltransferase [hmtase] and process of preparation thereof |
| 03/05/2009 | WO2006137934A3 Purposeful movement of human migratory cells away from an agent source |
| 03/05/2009 | WO2006117762A8 Antimicrobial agents |
| 03/05/2009 | WO2006083373A3 Methods and compositions for modulating keratinocyte function |
| 03/05/2009 | WO2005121138A3 Heterotricyclic compounds for use as hcv inhibitors |
| 03/05/2009 | WO2003048376A9 Modulation of immune-cell related disorders using il-1hy2 |
| 03/05/2009 | US20090064350 Detection and treatment of drug associated angioedema |
| 03/05/2009 | US20090062561 Deuterium-enriched latanoprost |
| 03/05/2009 | US20090062403 Compositions and Methods for Treatment of Disorders of Protein Aggregation |
| 03/05/2009 | US20090062402 Active substance combination of licochalcone a and phenoxyethanol |
| 03/05/2009 | US20090062401 Decaline-derived compounds as pharmaceutically active agents |
| 03/05/2009 | US20090062400 Method of treating glaucoma using rasagiline |
| 03/05/2009 | US20090062399 Deuterium-enriched sertraline |
| 03/05/2009 | US20090062398 Deuterium-enriched tolterodine |
| 03/05/2009 | US20090062397 Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins |
| 03/05/2009 | US20090062396 Novel Haloalkoxy-Substituted Salicylic Anilides |
| 03/05/2009 | US20090062395 Renin inhibitors for the treatment of hypertension |
| 03/05/2009 | US20090062394 Transdermal delivery of ketoprofen polar derivatives |
| 03/05/2009 | US20090062393 Deuterium-enriched pregabalin |
| 03/05/2009 | US20090062392 Deuterium-enriched gabapentin |
| 03/05/2009 | US20090062391 Use of a virucidal ointment in the nares for prevention of transmission and contraction of common colds |
| 03/05/2009 | US20090062390 In-shower lotion compositions comprising up to 10% free fatty acids wherein ratio of unsaturated to saturated fatty acids is at least 1:1 |
| 03/05/2009 | US20090062389 In-Shower Lotion Compositions Comprising Up to 10% Free Fatty Acids Wherein Ratio of Unsaturated to Saturated Fatty Acids is at Least 1:1 |
| 03/05/2009 | US20090062388 Use of acetyl L-carnitine for the preparation of a medication for the preventive therapy for pain |
| 03/05/2009 | US20090062387 Method of preventing nephrocalcinosis |
| 03/05/2009 | US20090062386 Simulants of Toxants for Training and Testing |
| 03/05/2009 | US20090062385 Deuterium-enriched fesoterodine |
| 03/05/2009 | US20090062384 Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease |
| 03/05/2009 | US20090062383 Salts of Substituted Allophanates and Their Use in Drugs |
| 03/05/2009 | US20090062382 External preparation for improving coital function |
| 03/05/2009 | US20090062381 Aqueous composition |
| 03/05/2009 | US20090062380 Isoflavones for treating mucopolysaccharidoses |
| 03/05/2009 | US20090062379 Compositions and methods for treating immune disorders |
| 03/05/2009 | US20090062378 Nutraceutical Mangosteen Composition |
| 03/05/2009 | US20090062377 Anti-cancer combinations |
| 03/05/2009 | US20090062376 Preparation of Taxanes From 9-Dihydro-13-Acetylbaccatin III |
| 03/05/2009 | US20090062375 Methods and compositions for the treatment of viral diseases |
| 03/05/2009 | US20090062374 Deuterium-enriched lasofoxifene |
| 03/05/2009 | US20090062373 Deuterium-enriched pf-184298 |
| 03/05/2009 | US20090062372 Glycopyrronium Salts and Their Therapeutic Use |
| 03/05/2009 | US20090062371 Oral preparation for promoting synthesis of tissue collagen |
| 03/05/2009 | US20090062370 Method for increasing the speed of recovery and/or the speed of wound healing of injured animals |
| 03/05/2009 | US20090062369 Use of secretory phospholipase a2 (spla2) inhibitors to decrease spla2 levels |
| 03/05/2009 | US20090062368 Deuterium-enriched sunitinib |
| 03/05/2009 | US20090062367 Deuterium-enriched eletriptan |
| 03/05/2009 | US20090062366 Pyrrolidine derivative or salt thereof |
| 03/05/2009 | US20090062365 Pyrazoles for the Treatment of GERD and IBS |
| 03/05/2009 | US20090062364 Deuterium-enriched celecoxib |
| 03/05/2009 | US20090062363 Amide derivative or salt thereof |
| 03/05/2009 | US20090062362 Veterinary Formulation for Administration of a Water-Insoluble Drug to a Target Animal Through a Water Distribution System |
| 03/05/2009 | US20090062361 Therapeutic hydantoins |
| 03/05/2009 | US20090062360 Compounds Which Inhibit the Glycine Transporter and Uses Thereof |
| 03/05/2009 | US20090062359 Injectable capsaicin with non-local anesthetic sodium channel-blocker adjunctive agent |
| 03/05/2009 | US20090062358 Peroxisome proliferator activated receptor alpha agonists |
| 03/05/2009 | US20090062357 Deuterium-enriched fluconazole |
| 03/05/2009 | US20090062356 Substituted benzimidazole derivatives |
| 03/05/2009 | US20090062355 Pharmaceutical Product |
| 03/05/2009 | US20090062354 Method of increasing the extent of absorption of tizanidine |
| 03/05/2009 | US20090062353 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| 03/05/2009 | US20090062352 Deuterium-enriched amlodipine |
| 03/05/2009 | US20090062351 Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators |
| 03/05/2009 | US20090062349 1-Hydroxycycloalkanecarboxamide derivatives |
| 03/05/2009 | US20090062348 Antifungal Agent Containing Pyridine Derivative |
| 03/05/2009 | US20090062347 Deuterated axitinib (AG-13736), N-Methyl-2-[[3- [2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl]sulfanyl]benzamide; cancer treatment |
| 03/05/2009 | US20090062346 Deuterium-enriched tipranavir |
| 03/05/2009 | US20090062345 Amide derivatives as trpv1 antagonists |
| 03/05/2009 | US20090062344 Therapeutic substituted piperidone compounds |
| 03/05/2009 | US20090062343 Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 03/05/2009 | US20090062342 Amines |
| 03/05/2009 | US20090062341 Nuclear receptor binding agents |
| 03/05/2009 | US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 03/05/2009 | US20090062339 Compositions and methods for selective inhibition of nicotine acetylcholine receptors |
| 03/05/2009 | US20090062338 Nitroxides for use in treating or preventing cardiovascular disease |
| 03/05/2009 | US20090062337 Treatment of Microbial Infections |
| 03/05/2009 | US20090062336 Methods of Diminishing Co-Abuse Potential |
| 03/05/2009 | US20090062335 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | US20090062334 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | US20090062333 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 03/05/2009 | US20090062332 Disubstituted alkyl-8-azabicyclo[3.2.1] octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | US20090062331 Deuterium-enriched maraviroc |
| 03/05/2009 | US20090062330 Treatment of progressive neurodegenerative disease with ibudilast |